Welcome To Youth
What You Want Tomorrow,
You Have To Plan For Today
A Lifetime Engagement Strategy To Preserve Your Natural Beauty
The skin prejuvenation journey commences in your early 20’s, as the pathophysiological signs of ageing are already visible.
With a young team between the ages of 20 and 35, it occurred spontaneously that there is a requirement for our younger generation to originate a programme that is suitable and cost-effective to retain the youthful appearance of the skin.
Your CDC Youth Experience Starts Here
CDC Youth is designed to optimise.
State-of-the-art technology and unparalleled knowledge sets the stage to retain a youthful appearance.
Encounter the most recent skin care advice and technology.
Now is the perfect time to create skincare awareness amongst the younger crowd.
The Programme Consists Of 4 Steps
Epidermal Glow
Medical grade crystals exfoliate the outer skin surface, exposing living skin cells that are soft, smooth and receptive to nutrients. The underlying epidermis is stimulated to increase blood circulation and collagen formation. The treatment concludes with a highly hydrating, skin optimising antioxidant cocktail.
Dermal Glow
A pulsed light treatment treats photo-ageing, enlarged pores, elastosis and prevents the breakdown of collagen. New collagen growth has been proven to continue for 6-12 months after treatment. Pulsed light strengthens your skin, stimulates blood circulation and collagen production and gives your skin a healthy glow.
Intro-Tox
Performed by our Doctors. Subtle relaxation of facial muscles is an integral step in creating a youthful appearance. Botulinum Toxin A has been scientifically proven to keep the skin younger. The response is maintained for 3-4 months and tailored according to your needs. Ideally administered from your late 20’s.
I-Youth
Performed by our Doctors. Our state-of-the-art injectable skin quality enhancement treatment maintains improved hydration and elasticity for 6-9 months after a single injectable treatment of Hyaluronic Acid. Ideally administered from age 30.